| Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study P Bettica, G Cline, DJ Hart, J Meyer, TD Spector Arthritis & Rheumatism 46 (12), 3178-3184, 2002 | 403 | 2002 |
| Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. M Varenna, F Zucchi, D Ghiringhelli, L Binelli, M Bevilacqua, P Bettica, ... The Journal of rheumatology 27 (6), 1477-1483, 2000 | 297 | 2000 |
| A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety T Furmark, L Appel, S Henningsson, F Åhs, V Faria, C Linnman, ... Journal of Neuroscience 28 (49), 13066-13074, 2008 | 274 | 2008 |
| Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn’s disease and ulcerative colitis S Ardizzone, S Bollani, P Bettica, M Bevilacqua, P Molteni, ... Journal of internal medicine 247 (1), 63-70, 2000 | 261 | 2000 |
| Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging V Nicolas, A Prewett, P Bettica, S Mohan, RD Finkelman, DJ Baylink, ... The Journal of Clinical Endocrinology & Metabolism 78 (5), 1011-1016, 1994 | 252 | 1994 |
| High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in northern Italy for initial screening P Bettica, M Bevilacqua, T Vago, G Norbiato Osteoporosis international 9, 226-229, 1999 | 185 | 1999 |
| Histological effects of givinostat in boys with Duchenne muscular dystrophy P Bettica, S Petrini, V D'Oria, A D'Amico, M Catteruccia, M Pane, S Sivo, ... Neuromuscular Disorders 26 (10), 643-649, 2016 | 167 | 2016 |
| Evidence of altered bone turnover, vitamin D and calcium regulation with knee osteoarthritis in female twins DJ Hunter, D Hart, H Snieder, P Bettica, R Swaminathan, TD Spector Rheumatology 42 (11), 1311-1316, 2003 | 152 | 2003 |
| Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared P Bettica, L Moro, SP Robins, AK Taylor, J Talbot, FR Singer, DJ Baylink Clinical chemistry 38 (11), 2313-2318, 1992 | 146 | 1992 |
| Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat S Consalvi, C Mozzetta, P Bettica, M Germani, F Fiorentini, F Del Bene, ... Molecular Medicine 19, 79-87, 2013 | 138 | 2013 |
| Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis JA Andrews, CE Jackson, TD Heiman-Patterson, P Bettica, BR Brooks, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21 (7-8), 509-518, 2020 | 110 | 2020 |
| Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of … P Bettica, L Squassante, JA Groeger, B Gennery, R Winsky-Sommerer, ... Neuropsychopharmacology 37 (5), 1224-1233, 2012 | 96 | 2012 |
| The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomnia P Bettica, L Squassante, S Zamuner, G Nucci, H Danker-Hopfe, E Ratti Sleep 35 (8), 1097-1104, 2012 | 94 | 2012 |
| Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder V Faria, L Appel, F Åhs, C Linnman, A Pissiota, Ö Frans, M Bani, P Bettica, ... Neuropsychopharmacology 37 (10), 2222-2232, 2012 | 82 | 2012 |
| Effect of fluvastatin on lipids and fibrinolysis in coronary artery disease M Bevilacqua, P Bettica, M Milani, T Vago, A Rogolino, V Righini, ... American Journal of Cardiology 79 (1), 84-87, 1997 | 82 | 1997 |
| Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist P Bettica, G Nucci, C Pyke, L Squassante, S Zamuner, E Ratti, R Gomeni, ... Journal of Psychopharmacology 26 (8), 1058-1070, 2012 | 73 | 2012 |
| A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial SJ Mathew, M Vythilingam, JW Murrough, CA Zarate Jr, A Feder, ... European Neuropsychopharmacology 21 (3), 221-229, 2011 | 73 | 2011 |
| Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder E Ratti, K Bellew, P Bettica, H Bryson, S Zamuner, G Archer, ... Journal of clinical psychopharmacology 31 (6), 727-733, 2011 | 72 | 2011 |
| Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies E Ratti, P Bettica, R Alexander, G Archer, D Carpenter, G Evoniuk, ... Journal of psychopharmacology 27 (5), 424-434, 2013 | 70 | 2013 |
| Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo S Hilliker, JE Wergedal, HE Gruber, P Bettica, DJ Baylink Bone 19 (5), 469-477, 1996 | 65 | 1996 |
